相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates
Ke Wang et al.
BIOMATERIALS (2014)
Acute Depletion of Endothelial β3-Integrin Transiently Inhibits Tumor Growth and Angiogenesis in Mice
Veronica Steri et al.
CIRCULATION RESEARCH (2014)
Neuropilin 1 (NRP1) hypomorphism combined with defective VEGF-A binding reveals novel roles for NRP1 in developmental and pathological angiogenesis
Alessandro Fantin et al.
DEVELOPMENT (2014)
RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system
Yu Sakurai et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells
Claudio Raimondi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
A heterodimeric [RGD-Glu-[64Cu-NO2A]-6-Ahx-RM2] αvβ3/GRPr-targeting antagonist radiotracer for PET imaging of prostate tumors
Kubra Durkan et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Synthesis and biological evaluation of dual action cyclo-RGD/SMAC mimetic conjugates targeting a(v)beta(3)/a(v)beta(5) integrins and IAP proteins
M. Mingozzi et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2014)
The cytoplasmic domain of neuropilin-1 regulates focal adhesion turnover
Himabindu Reddy Seerapu et al.
FEBS LETTERS (2013)
β1- and αv-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments
Herbert B. Schiller et al.
NATURE CELL BIOLOGY (2013)
Label-Free Luminescent Mesoporous Silica Nanoparticles for Imaging and Drug Delivery
Hongmin Chen et al.
THERANOSTICS (2013)
Molecular Dynamics Reveal that isoDGR-Containing Cyclopeptides Are True αvβ3 Antagonists Unable To Promote Integrin Allostery and Activation
Michela Ghitti et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
Fabienne Danhier et al.
MOLECULAR PHARMACEUTICS (2012)
Integrin β3 Crosstalk with VEGFR Accommodating Tyrosine Phosphorylation as a Regulatory Switch
Xiaoxia Z. West et al.
PLOS ONE (2012)
Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output
Kurt Ballmer-Hofer et al.
BLOOD (2011)
The role of β3-integrins in tumor angiogenesis: context is everything
Stephen D. Robinson et al.
CURRENT OPINION IN CELL BIOLOGY (2011)
Quantitative proteomics of the integrin adhesome show a myosin II-dependent recruitment of LIM domain proteins
Herbert B. Schiller et al.
EMBO REPORTS (2011)
VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation
Birger Herzog et al.
MOLECULAR BIOLOGY OF THE CELL (2011)
Integrin Targeted Delivery of Chemotherapeutics
Kai Chen et al.
THERANOSTICS (2011)
Endothelial α5 and αv integrins cooperate in remodeling of the vasculature during development
Arjan van der Flier et al.
DEVELOPMENT (2010)
Dissection of platelet and myeloid cell defects by conditional targeting of the β3-integrin subunit
Elizabeth A. Morgan et al.
FASEB JOURNAL (2010)
αvβ3 Integrin Limits the Contribution of Neuropilin-1 to Vascular Endothelial Growth Factor-induced Angiogenesis
Stephen D. Robinson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Use of a Novel Arg-Gly-Asp Radioligand, F-18-AH111585, to Determine Changes in Tumor Vascularity After Antitumor Therapy
Matthew S. Morrison et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors
Andrew R. Reynolds et al.
NATURE MEDICINE (2009)
The Integrin Antagonist Cilengitide Activates αVβ3, Disrupts VE-Cadherin Localization at Cell Junctions and Enhances Permeability in Endothelial Cells
Gian Carlo Alghisi et al.
PLOS ONE (2009)
Neuropilin-1/GIPC1 Signaling Regulates alpha 5 beta 1 Integrin Traffic and Function in Endothelial Cells
Donatella Valdembri et al.
PLOS BIOLOGY (2009)
Integrin αvβ3-Targeted Radioimmunotherapy of Glioblastoma Multiforme
Anand Veeravagu et al.
CLINICAL CANCER RESEARCH (2008)
Integrin αvβ3-Targeted Cancer Therapy
Zhaofei Liu et al.
DRUG DEVELOPMENT RESEARCH (2008)
Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide-paclitaxel conjugate in mice with breast cancer
Qizhen Cao et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
The angiogenic response is dictated by β3 integrin on bone marrow-derived cells
Weiyi Feng et al.
JOURNAL OF CELL BIOLOGY (2008)
Integrin-targeted imaging and therapy with RGD4C-TNF fusion protein
Hui Wang et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery
Caroline Bouzin et al.
DRUG RESISTANCE UPDATES (2007)
Direct targeting of αvβ3 integrin on tumor cells with a monoclonal antibody, Abegrin™
Kathy Mulgrew et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Integrin signaling is critical for pathological angiogenesis
Ganapati H. Mahabeleshwar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
TNF-α in cancer treatment:: Molecular insights, antitumor effects, and clinical utility
Remco van Horssen et al.
ONCOLOGIST (2006)
Elevated Flk1 (vascular endothelial growth factor receptor 2) signaling mediates enhanced angiogenesis in β3-integrin-deficient mice
AR Reynolds et al.
CANCER RESEARCH (2004)
The role of the AlphaVbeta3 integrin in the development of osteolytic bone metastases: A pharmacological target for alternative therapy?
A Teti et al.
CALCIFIED TISSUE INTERNATIONAL (2002)
Integrins: Bidirectional, allosteric signaling machines
RO Hynes
CELL (2002)
VEGF(165) mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF(165)-receptor binding
S Soker et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2002)
Enhanced pathological angiogenesis in mice lacking beta(3) integrin or beta(3) and beta(5) integrins
LE Reynolds et al.
NATURE MEDICINE (2002)
Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF165 and VEGF121
GB Whitaker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
分享论文
